Lisata sues Kuva Labs after merger collapse, cuts 72% of staff

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Lisata sues Kuva Labs after merger collapse, cuts 72% of staff

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

August 4, 2026 7:00 AM EDT

Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages for the benefit of its stockholders

Lisatas Board of Directors and management continues to evaluate strategic alternatives to enhance stockholder value

In order to reduce operating expenses and preserve cash to pursue strategic alternatives, Lisata has implemented a reduction in force of approximately 72% of its full-time employees

LIBERTY CORNER, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (Lisata), a clinical-stage pharmaceutical company... More